Diabetes mellitus treatment with insulin pump: clinical effectiveness - indications
Pichon Riviere A, Augustovski F, Cernadas C, Ferrante D, Regueiro A, Garcia Marti S
Record ID 32005000651
Spanish
Authors' objectives:
This study aims to summarise the available evidence on insulin pumb treatment of diabetes mellitus.
Authors' results and conclusions:
Different trials show a slight reduction in the Hb A1c percentages and in the total dose of insulin required to control the glycemia levels when compared with MDI. However, they do not conclusively mean a better metabolic control than that of intensive regimens with multiple injections. Some authors recommend its use when an intensive treatment with adequate patient self-monitoring does not get the desired therapeutic outcome.
Authors' recommendations:
CSII represents a higher cost in diabetes type 1 treatment and though it suggests a better quality of life for patients as they obtain better flexibility for intake times, or in cases of changing social and working lifestyles, its cost-effectiveness over MDI is not clear.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.iecs.org.ar/
Year Published:
2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Insulin Infusion Systems
- Diabetes Mellitus, Type 1
- Hypoglycemia
- Insulin
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.